We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+15.27%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$17.3B
AUM Growth
+$1.38B
Cap. Flow
-$440M
Cap. Flow %
-2.54%
Top 10 Hldgs %
32.07%
Holding
728
New
61
Increased
216
Reduced
343
Closed
55

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$85M
2
ABT icon
Abbott
ABT
+$53.8M
3
EXC icon
Exelon
EXC
+$46.6M
4
BSX icon
Boston Scientific
BSX
+$42.6M
5
ABBV icon
AbbVie
ABBV
+$32.4M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$80.5M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$54.5M
3
CRWD icon
CrowdStrike
CRWD
+$45.7M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$40.6M
5
MRK icon
Merck
MRK
+$39.3M

Sector Composition

Rank Sector Weight
1 Technology 36.26%
2 Healthcare 22.78%
3 Financials 10.33%
4 Consumer Discretionary 7.75%
5 Industrials 7.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FITB
451
Fifth Third Bancorp
FITB
$52B
$2.54M 0.01%
61,696
-71,067
-54% -$2.67M
YUM icon
452
Yum! Brands
YUM
$41.7B
$2.54M 0.01%
17,111
-1,962
-10% -$286K
RMD icon
453
ResMed
RMD
$30.4B
$2.53M 0.01%
9,799
-296
-3% -$70.6K
NLY icon
454
Annaly Capital Management
NLY
$17.2B
$2.51M 0.01%
133,255
-3,185
-2% -$60.6K
ARKK icon
455
ARK Innovation ETF
ARKK
$5.6B
$2.5M 0.01%
35,520
EFX icon
456
Equifax
EFX
$22.2B
$2.47M 0.01%
9,526
-457
-5% -$116K
XYZ
457
Block Inc
XYZ
$48.4B
$2.47M 0.01%
36,293
-37,907
-51% -$2.21M
MLM icon
458
Martin Marietta Materials
MLM
$34.8B
$2.46M 0.01%
4,486
+430
+11% +$227K
PCVX icon
459
Vaxcyte
PCVX
$7.94B
$2.43M 0.01%
74,717
-38,673
-34% -$1.27M
KHC icon
460
Kraft Heinz
KHC
$32.8B
$2.42M 0.01%
93,550
-4,227
-4% -$117K
HUM icon
461
Humana
HUM
$44.8B
$2.41M 0.01%
9,870
-15,413
-61% -$3.84M
CHTR icon
462
Charter Communications
CHTR
$16.5B
$2.41M 0.01%
5,892
-51
-0.9% -$19.5K
ROST icon
463
Ross Stores
ROST
$80.3B
$2.31M 0.01%
18,104
+3,962
+28% +$550K
EXE
464
Expand Energy Corp
EXE
$21.6B
$2.26M 0.01%
+19,366
New +$2.16M
CAG icon
465
Conagra Brands
CAG
$7.5B
$2.23M 0.01%
109,137
+9,449
+9% +$221K
DOC icon
466
Healthpeak Properties
DOC
$15.6B
$2.21M 0.01%
126,211
+15,077
+14% +$268K
FOXA icon
467
Fox Class A
FOXA
$24.3B
$2.2M 0.01%
39,242
-5,365
-12% -$283K
EQH icon
468
Equitable Holdings
EQH
$13.3B
$2.17M 0.01%
38,597
-2,631
-6% -$135K
CFG icon
469
Citizens Financial Group
CFG
$30.3B
$2.12M 0.01%
47,345
-22,224
-32% -$875K
K
470
DELISTED
Kellanova
K
$2.11M 0.01%
26,554
-163
-0.6% -$13.3K
FANG icon
471
Diamondback Energy
FANG
$55.5B
$2.1M 0.01%
15,271
-290
-2% -$40.2K
ADM icon
472
Archer Daniels Midland
ADM
$40.8B
$2.09M 0.01%
39,668
-19,220
-33% -$935K
ERII icon
473
Energy Recovery
ERII
$437M
$2.09M 0.01%
163,157
+181
+0.1% +$2.45K
DHI icon
474
D.R. Horton
DHI
$42.3B
$2.07M 0.01%
16,037
-3,654
-19% -$450K
WFG icon
475
West Fraser Timber
WFG
$5.3B
$2.03M 0.01%
27,688

Similar funds

Candriam SCA's Q2 2025 Portfolio in Review

As of Q2 2025, Candriam SCA held 728 positions worth $17.3B, up 8.6% from $16B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Candriam SCA's Q2 2025 filing shows 61 new, 216 increased, 343 reduced and 55 closed positions. Its largest new stake was Tapestry: 260,834 shares worth $22.9M. The largest sale was Tesla, an estimated $80.5M.

By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 32% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q2 2025 buy was Tapestry: 260,834 shares worth $22.9M.
  • Candriam SCA added most to Broadcom in Q2 2025, an estimated $85M increase.
  • Candriam SCA's biggest Q2 2025 reduction was Tesla, cutting an estimated $80.5M.
  • Candriam SCA fully exited Banco Macro in Q2 2025, selling an estimated $17.6M.
  • Candriam SCA's ten largest holdings make up 32% of its $17.3B portfolio in Q2 2025.
  • Candriam SCA opened 61 new positions and closed 55 in Q2 2025.
  • Candriam SCA's portfolio value rose 8.6% quarter-over-quarter to $17.3B.

Based on Candriam SCA's 13F filing for Q2 2025, filed 8 Aug 2025.